MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 4.40M | 3.82M | 3.76M | 4.08M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 31.50M | 30.66M | 23.54M | 20.89M | |
| Operating Income | -31.50M | -30.66M | -23.54M | -20.89M | |
| Income Before Tax | -29.42M | -29.85M | -22.34M | -19.02M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -29.42M | -29.85M | -22.34M | -19.02M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -29.42M | -29.85M | -22.34M | -19.02M | |
| EBIT | -31.50M | -30.66M | -23.54M | -20.89M | |
| EBITDA | -31.36M | -30.53M | -23.38M | -20.71M | |
| EPS Basic | -37.18 | -39.11 | -29.33 | -25.08 | |
| Normalized Basic EPS | -23.24 | -24.61 | -18.33 | -15.68 | |
| EPS Diluted | -37.18 | -39.11 | -29.33 | -25.08 | |
| Normalized Diluted EPS | -23.24 | -24.61 | -18.33 | -15.68 | |
| Average Basic Shares Outstanding | 791.10K | 763.10K | 761.60K | 758.20K | |
| Average Diluted Shares Outstanding | 791.10K | 763.10K | 761.60K | 758.20K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |